Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

SHE:301281 Revenue

Shandong Keyuan Pharmaceutical had revenue of 161.30M CNY in the quarter ending March 31, 2026, with 45.05% growth. This brings the company's revenue in the last twelve months to 448.33M, up 4.59% year-over-year. In the year 2025, Shandong Keyuan Pharmaceutical had annual revenue of 398.23M, down -14.12%.

• Revenue (ttm): 448.33M
• Revenue Growth: +4.59%
• P/S Ratio: 9.50
• Revenue / Employee: 644.15K
• Employees: 696
• Market Cap: 4.26B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	398.23M	-65.49M	-14.12%
Dec 31, 2024	463.72M	16.13M	3.60%
Dec 31, 2023	447.58M	4.72M	1.07%
Jan 1, 2023	442.87M	21.98M	5.22%
Jan 1, 2022	420.89M	53.83M	14.67%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 3, 2026

Data Sources Report a data error